Table 2.
Age/sex | Donor (age), HLA match, and ABO compatible | Engraftment day/granulocyte transfusion days | Myeloid/CD3+ cell chimerism | aGVHD grades/cGVHD severity | Viral reactivation/intervention | Post-transplant infections | Follow-up or cause of death/interval |
---|---|---|---|---|---|---|---|
14/M | Father (33), 8/10, yes | PMN 15, platelets 14/5 and 11 | 100/≥ 97% from first assessment | Grade 2 acute GI/no | EBV/none Grade 2 HC with BK viruria | C. difficile-associated diarrhea | Resolved Nocardia pneumonia 18 months, persistent PLE, cure/> 3 years |
26/F | Mother (45), 10/10, yes | PMN 21, platelets 23/9, 10, 12, 13, and 14 | 100/≥ 98% from first assessment | Grade 2 acute GI, grade 1 skin/no | CMV/preemption EBV/none | S. aureus sternal wound infection | Aspergillus infection resolved 11 months, Cure/> 3 years |
24/M | Brother (18), 8/10, yes | PMN 17, platelets 31 | 100/100% at all points | Grade 2 acute skin and grade 1 GI/yes, mild-limited | EBV/none Grade 1 HC with BK viruria | C. difficile-associated diarrhea | Cure > 3 years |
16/M | Father (43), 5/10, yes | PMN 12, platelets 19 | 100/100% at all points | Grade 3 skin, GI/ mild | CMV/preemption EBV/none Grade III HC with BK viruria |
A. fumigatus pneumonia E. coli bacteremia B. fragilis bacteremia |
Cure > 2 years |
14/M | Father (34), 6/10, yes | PMN 24, platelets 17/9, 21 | 100/100% at all points | Grade 2 GI | EBV/none CMV colitis/treatment | S. mitis bacteremia | Resolved fungal pneumonia/pericarditis 12 months, cure > 4 years |
22/F | Father (53), 5/10, yes | PMN 20, Platelets 29 | 96–100%, 98–100% | Steroid-refractory GI | EBV/none Disseminated adenovirus | K. pneumoniae/E.coli pneumonia | Death day 131 |
19/M | Father (52), 3/6, yes | PMN 22, platelets 107 | 100/100% At all points | Liver steroid- refractory GI | EBV PTLD/rituximab CMV/preemption Grade III HC with BK viruria | E. faecium bacteremia Nocardia/Enterobacter pneumonia Rhizopus sp. pneumonia | Death day 316 |
HLA human leukocyte antigen, PMN polymorphonuclear leukocytes, aGVHD acute graft-versus-host disease, cGVHD chronic graft-versus-host disease, GI gastrointestinal, EBV Epstein-Barr virus, CMV cytomegalovirus, PTLD post-transplant lymphoproliferative disease, HC hemorrhagic cystitis,C. difficile Clostridioides difficile, S. aureus Staphylococcus aureus, A. fumigatus, Aspergillus fumigatus, E. coli Escherichia coli, B. fragilis Bacteroides fragilis, S. mitis Streptococcus mitis, K. pneumoniae Klebsiella pneumoniae, E. faecium Enterococcus faecium, PLE protein-losing enteropathy